Leiden University Medical Center (LUMC, The Netherlands), is a university medical centre for research, education and patient care with a high-quality profile and a strong scientific orientation. It has a unique research practice, ranging from pure fundamental biomedical research to applied clinical research. LUMC is a centre for medical innovation, committed to the advancement of health care and innovative education in line with the latest international insights and standards - and aims to play a nationally and internationally recognised leading role in improving medicine and the quality of health care and people’s health. 

The health of the global population is one of the biggest challenges of our time. Therefore, LUMC believes in curing but also in prevention. Within the LUMC, the Leiden Controlled Human Infection Center is a node of expertise which performs first-in-human clinical trials to test novel vaccines as efficiently as possible and develops novel technologies to allow for downstream clinical development in endemic areas. Its state-of-the-art facilities are exploited to develop vaccines for the global population with a specific focus on poverty-related diseases.

​

https://www.lumc.nl